All GP articles
-
InformationGINA ASTHMA STRATEGY 2020
Asthma affects an estimated 300 million individuals worldwide, and still imposes an unacceptable burden on healthcare systems, society through loss of productivity in the workplace, and, especially for paediatric asthma, disruption to the family. Asthma affects all age groups and contributes to many deaths worldwide. The Global Initiative for ...
-
Upcoming Live Webinars
Opioid-induced constipation: optimal management and the role of PAMORA drugs
This webinar has been initiated and commissioned by Sandoz Ltd and organised in partnership with Guidelines . Sandoz Ltd has reviewed the scope of the webinar, commissioned the speakers, and approved all materials related to the webinar. The speakers have been paid an honorarium. The views and opinions of the ...
-
Working party guideline/algorithm
Inhaler choice guideline
Information is intended for healthcare professionals only. This management algorithm was developed by MGP Ltd and supported by Chiesi Ltd through the provision of a grant for its production. Chiesi Ltd had no editorial control other than to check factual accuracy. See end of algorithm for ...
-
Independent professional body guideline
PCDE pharmacological management of type 2 diabetes
This succint summary highlights the treatment recommendations for type 2 diabetes by cardiovascular/renal disease or risk factor.
-
Independent professional body guideline
BSR giant cell arteritis guideline
This summary outlines the general principles of identifying and treating patients with giant cell arteritis in primary care and specialist settings. It is recommended that general practitioners refer patients with suspected giant cell arteritis to a clinician with appropriate specialist expertise.
-
PHE/DH/DWP guideline
PHE whooping cough vaccination in pregnancy guideline
A concise summary covering the pertussis vaccination programme for pregnant women.
-
Information
Key COVID-19 guidance for primary care
The Guidelines team has produced the following directory of COVID-19 information and guidance for primary care. Included on this page is a collection of key guidance and advice from PHE and the NHS, as well as a list of information for specific groups from a range of professional bodies. ...
-
Independent professional body guideline
GINA strategy 2020: assessing patients with asthma
This Guidelines summary outlines recommendations for assessing patients with asthma. Please refer to the full report for the complete set of recommendations.
-
Independent professional body guideline
GINA strategy 2020: asthma–COPD overlap
This Guidelines summary outlines recommendations for the diagnosis and initial treatment of adults with features of asthma, chronic obstructive pulmonary disease (COPD), or both.
-
Independent professional body guideline
GINA strategy 2020: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged six to 11.
-
Independent professional body guideline
GINA strategy 2020: diagnosis of asthma
This Guidelines summary outlines recommendations for making the diagnosis of asthma in adults and children over five years of age. Please refer to the full report for the complete set of recommendations.
-
NHS guideline
PHE maintaining immunisation programmes during COVID-19 guideline
A brief summary providing the key points for primary care on maintaining immunisation programmes during the COVID-19 pandemic.
-
Working party guideline/algorithm
Women of child-bearing age with inflammatory rheumatic diseases guideline
This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of a grant from UCB Pharma Ltd.
-
On demand webinars
A practical approach to COPD treatment: case studies to support patient care*
This webinar has been organised and funded by GSK UK. See bottom of page for full disclaimer. *This GSK webinar contains promotional content Video: A practical approach to COPD treatment: case studies to support patient care Incruse▼Ellipta (umeclidinium bromide): prescribing information Anoro▼Ellipta ...
-
NICE guideline
NICE antenatal and postnatal mental health guideline
A concise NICE guideline summary on the management of women with mental health problems during pregancy planning, pregnancy, and the postnatal period.
-
PHE/DH/DWP guideline
PHE PSA prostate cancer test guideline
A concise summary of PHE's guidance on PSA testing in men over 50 years old. Includes a useful algorithm.
-
NHS guideline
NHS video consulting guideline
This Guidelines summary covers guidance for safe video consulting in general practice. It includes key principles, general information, and recommendations on conducting safe video consultations. Refer to the full guideline for information on: information governance communication with colleagues medico-legal information ...
-
NICE guideline
NICE MS guideline
A brief NICE guidance summary relevant to primary care about diagnosis of MS, support for patients, and modifiable risk factors for relapse and progression.
-
Checklist
Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for eligible patients with DVT or PE*
Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines . Please see the bottom of the page for full disclaimer. View Xarelto (rivaroxaban) prescribing information and adverse event reporting information Download ...
-
Independent professional body guideline
PCWHF HRT provision during COVID-19 guidance
This summary is intended to aid primary healthcare practitioners in initiating, reviewing, and prescribing hormone replacement therapy for women during COVID-19.
